Also trades as: RAD.AX (ASX) · $vol 0M
RADX NASDAQ
Radiopharm Theranostics Limited
1W: -12.1%
1M: -32.9%
3M: -66.7%
YTD: -71.9%
1Y: -74.7%
$1.42
-0.06 (-4.05%)
Weekly Expected Move ±15.7%
$1
$1
$1
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$37M
-59.5% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$37M
-59.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$11M
+53.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Operating Activities — | ||||
| Net Income | -$30M | -$35M | -$48M | $0 |
| Depreciation & Amort. | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in Working Capital | $0 | $0 | $0 | $0 |
| Other Non-Cash Items | $20M | $11M | $25M | -$37M |
| Operating Cash Flow | -$10M | -$23M | -$23M | -$37M |
| — Investing Activities — | ||||
| Capital Expenditures | -$3K | -$45K | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 |
| Other Investing | -$28M | -$1M | -$320K | $2M |
| Investing Cash Flow | -$28M | -$2M | -$320K | $2M |
| — Financing Activities — | ||||
| Net Debt Issuance | -$59K | $0 | $2M | -$2M |
| Stock Repurchased | -$5M | -$855K | -$2M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | -$117K | -$7M |
| Financing Cash Flow | $65M | $9M | $30M | $45M |
| Net Change in Cash | $27M | -$15M | $7M | $11M |
| Cash End of Period | $27M | $12M | $19M | $29M |
| Free Cash Flow | -$38M | -$25M | -$23M | -$37M |